What were the biggest filings this week?
Ranked by company size, importance and dollar value
- 1
Marvell agreed to buy Lumentum in an all-stock merger: each Lumentum share converts into 4.500 Marvell shares. After closing, Marvell will add three directors designated by Lumentum to its board.
8-K Item 1.01 · Nov 20001193125-26-4427178-K Item 1.01, 5.02, 7.01 · Nov 20001193125-26-442758 - 2OracleORCLFinancing
Oracle sold 86,206,897 new shares for $10B and $10B of notes in five tranches, from 7.000% notes due 2029 to 8.650% notes due 2046. Both offerings closed on November 4.
8-K Item 8.01 · Nov 40001193125-26-447507 - 3
Kimberly-Clark completed its Kenvue acquisition: each Kenvue share became 0.14625 K-C shares plus $3.50 in cash, about 281 million new K-C shares in total. A Kenvue integration program is expected to cost about $3.1B before tax ($2.5B in cash) through 2029.
8-K Item 2.01, 2.05, 5.02, 5.03, 7.01 · Nov 20001104659-26-120990 - 43MMMMSettlement
3M agreed to contribute a nominal $7.35B from 2026 to 2034 to resolve most PFAS personal injury claims in the federal AFFF litigation, subject to claimant participation thresholds, and will book a pre-tax charge of about $5.8B in Q4 2026. 3M admits no liability.
8-K Item 1.01, 8.01 · Nov 40000066740-26-000318 - 5IntelINTCCEO buy
CEO Lip-Bu Tan bought 150,000 shares on November 2 in several open-market trades between $64.705 and $64.735, about $9.7M (code P). He held 1,464,669 shares afterward.
Form 4 filed Nov 4, trade Nov 2
What did insiders buy and sell?
Officer and director sales rose to $1.96B, 3.5 times the prior week and the most since the week of September 21. Many companies reopen insider trading windows after their earnings releases, and 1,359 8-Ks this week carried Item 2.02. Buys rose to $323M, the most since the week of August 17, but about $141M of that (44%) came at single offering-style prices and is left out of the table below.
Open-market buys, by week
Officers and directors, Form 4s filed each week
Show data
| Week of | Value |
|---|---|
| Aug 17, 2026 | $430M |
| Aug 24, 2026 | $112M |
| Aug 31, 2026 | $129M |
| Sep 7, 2026 | $130M |
| Sep 14, 2026 | $97.9M |
| Sep 21, 2026 | $225M |
| Sep 28, 2026 | $283M |
| Oct 5, 2026 | $166M |
| Oct 12, 2026 | $128M |
| Oct 19, 2026 | $36.5M |
| Oct 26, 2026 | $111M |
| Nov 2, 2026 | $323M |
Open-market sales, by week
Same weeks, different scale from buys
Show data
| Week of | Value |
|---|---|
| Aug 17, 2026 | $3.90B |
| Aug 24, 2026 | $2.63B |
| Aug 31, 2026 | $2.01B |
| Sep 7, 2026 | $1.64B |
| Sep 14, 2026 | $2.19B |
| Sep 21, 2026 | $2.02B |
| Sep 28, 2026 | $1.04B |
| Oct 5, 2026 | $1.28B |
| Oct 12, 2026 | $857M |
| Oct 19, 2026 | $548M |
| Oct 26, 2026 | $560M |
| Nov 2, 2026 | $1.96B |
| Company | Who | Trade dates | Value | Avg price |
|---|---|---|---|---|
| MGM ResortsMGM | Keith Meister, director About 1.75 million shares | 10/30 to 11/2 | $51.7M | $29.64 |
| Madrigal PharmaceuticalsMDGL | Baker Bros. Advisors, director | 11/4 to 11/6 | $35.0M | $381.49 |
| StrideLRN | 2 directors | 10/30 to 11/3 | $19.2M | $76.95 |
| Kinder MorganKMI | Richard Kinder, Executive Chairman 500,000 shares in several trades | 11/6 | $15.0M | $29.99 |
| Galaxy DigitalGLXY | Michael Novogratz, CEO | 11/5 | $9.9M | $12.98 |
| IntelINTC | Lip-Bu Tan, CEO 150,000 shares in several trades | 11/2 | $9.7M | $64.73 |
| Upbound GroupUPBD | 7 insiders incl. CEO and CFO | 11/2 to 11/3 | $1.3M | $22.71 |
| Company | Who | Trade dates | Value | Avg price |
|---|---|---|---|---|
| American ExpressAXP | Stephen Squeri, CEO | 11/4 | $99.4M | $332.16 |
| AmphenolAPH | Adam Norwitt, CEO | 11/2 | $65.9M | $82.48 |
| Kiniksa PharmaceuticalsKNSA | Sanj Patel, CEO | 10/30 to 11/4 | $51.7M | $93.41 |
| LindeLIN | Matthew White, CFO | 11/4 | $45.3M | $521.21 |
| United TherapeuticsUTHR | Martine Rothblatt, CEO | 10/30 to 11/5 | $28.3M | $595.75 |
| Marriott InternationalMAR | Anthony Capuano, CEO | 11/4 | $26.6M | $420.12 |
Large executive sales are often made under prearranged 10b5-1 plans, so they say less than buys; each Form 4 footnote says whether a plan was used. Left out of the buy table: purchases at a single offering-style price (Bambusa Therapeutics, BBTX, $46.0M at $16.00; KNOT Offshore Partners, KNOP, $43.5M at $20.88; Kodiak Sciences, KOD, $24.3M at $98.51; Aspen Neuroscience, ASPE, $15.0M at $15.00), two buys at about $1 and a SPAC.
What did the 8-Ks say?
8-Ks rose to 2,344 from 1,672, the most since the week of August 3, and 1,359 of them carried Item 2.02 (earnings release). One 8-K can carry several items, so the counts add up to more than 2,344.
- 2.02Earnings release1,359
- 7.01Reg FD disclosure662
- 8.01Other events371
- 5.02Officer or director change229
- 1.01Material agreement217
- 2.03New debt113
- 3.02Unregistered stock sale99
- 5.07Shareholder vote78
- 5.03Bylaw amendment62
- 2.01Deal completed42
- 3.03Holder rights changed38
Deals and closings
- FoxFOX+RokuROKUCompleted the Roku acquisition: each Roku share became 0.9799 FOX Class A shares plus $95.30 in cash8-K Item 1.01, 2.01, 2.03, 5.02, 7.01 · Nov 60001193125-26-451888
- onsemiONAgreed to buy Ferric for $600.0M in cash plus up to $175.0M tied to revenue milestones8-K Item 1.01, 7.01 · Nov 20001193125-26-443681
- DTE EnergyDTEAgreed to sell DTE Vantage for about $2.97B to a buyer owned by investors advised by J.P. Morgan Asset Management's Global Infrastructure group8-K Item 1.01 · Nov 50001193125-26-448536
Red flags
- Driven BrandsDRVNFiscal 2023 to 2025 statements and the first two 2026 quarterly reports can no longer be relied on and must be restated, its second such notice this year after February 238-K Item 2.02, 4.02 · Nov 30001628280-26-069090
- SoundHound AISOUNCutting about 27% of its global workforce, with $18M to $22M of pre-tax charges, mostly in Q4 20268-K Item 2.02, 2.05 · Nov 50001840856-26-000025
Leadership changes
- HPHPQEmma Walmsley becomes CEO on January 4, 2027; interim CEO Bruce Broussard steps down January 3 and becomes Board Chair8-K Item 5.02, 5.03, 7.01 · Nov 40001140361-26-041969
- Erie IndemnityERIECEO Timothy NeCastro retired November 2 instead of December 31; EVP Brian Bolash is interim President and CEO from November 38-K Item 5.02 · Nov 30001628280-26-069468
- Keysight TechnologiesKEYSJason Kary becomes CFO on December 18, succeeding Neil Dougherty8-K Item 5.02 · Nov 20001601046-26-000038
- PNC Financial ServicesPNCAlexander Overstrom, head of retail banking, becomes CFO on March 1, 2027, succeeding Robert Reilly8-K Item 5.02, 7.01 · Nov 50001628280-26-071110
Investment
- Freeport-McMoRanFCXBoard approved a $4.5B expansion and modernization of its wholly owned Bagdad copper and molybdenum operation in Arizona8-K Item 8.01 · Nov 40000831259-26-000048
Activists and funds
13D stakes
No activist 13D this week. The only 13D from a tracked filer was Third Point reporting a 161,000-share seed stake, 100% of the class, in Third Point Private Capital Income Fund, a new fund its affiliate advises (filed November 5).
13F holdings
Third-quarter 13Fs are due Monday, November 16, because November 14 falls on a Saturday. 26 of the filers SignalX tracks filed this week, after 7 in each of the two weeks before; last quarter 80 arrived in the deadline week alone (August 10 to 14). Corrected November 15: the first version said none were filed, because this week's filings had not been collected yet.
Frequently asked questions
What is the SignalX Weekly?
A weekly summary of what U.S. companies filed with the SEC: 8-K events, Form 4 insider trades, 13D stakes and 13F deadlines. SignalX collects the filings from EDGAR, counts them, and links every highlighted item to its source filing.
Why do insider sales rise after earnings?
Many companies close the trading window for officers and directors before an earnings release and reopen it shortly after. In this issue's week, 1,359 8-Ks carried Item 2.02 (earnings release), and officer and director sales rose to $1.96B from $560M the week before.
How are the insider totals counted?
Open-market purchases (code P) and sales (code S) of non-derivative shares by officers and directors, from Form 4s filed Monday to Friday. Duplicate joint filings are removed and prices above $20,000 a share are dropped as data errors.
Is this investment advice?
No. It reports what companies and insiders disclosed in public filings. Check the original filing before acting on anything here.
Data and method
Source: SEC EDGAR filings collected and classified by SignalX. 8-Ks filed Nov 2 to Nov 8; insider figures cover officer and director open-market purchases (P) and sales (S) of non-derivative shares on Form 4s filed Nov 2 to Nov 6, with joint-filing duplicates and prices above $20,000 a share removed. Importance scores (0 to 4) and event types come from SignalX's classification model. Data as of Nov 7, 2026.
SignalX Weekly summarizes public SEC filings for research. It is not investment advice. Figures are as of the data date above and can change if a filing is amended.
Follow these filings as they land
The insider screener and company pages update as new filings arrive on EDGAR.